BioLife Solutions, Inc. - Income Statement (TTM)

BioLife Solutions, Inc.
US ˙ NasdaqCM ˙ US09062W2044

Income Statement (TTM)

BioLife Solutions, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 42 48 53 74 97 119 139 148 155 76 155 143 126 76 65 56 63 82 88 93
Change (%) 15.44 9.74 40.33 30.41 23.38 16.26 6.73 4.70 -50.75 102.94 -7.30 -11.97 -39.92 -14.17 -14.63 12.59 31.43 6.70 6.50
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 17 20 23 37 57 81 98 106 108 29 98 90 75 30 21 9 12 29 31 33
Change (%) 21.50 14.74 60.54 53.76 41.30 20.86 7.81 2.03 -72.76 235.65 -8.11 -17.06 -60.12 -30.10 -55.96 29.29 140.01 6.87 8.12
% of Revenue 39.98 42.08 43.99 50.33 59.34 67.96 70.65 71.36 69.54 38.47 63.62 63.07 59.43 39.45 32.13 16.57 19.03 34.75 34.81 35.33
Gross Operating Profit 25 28 30 37 39 38 41 42 47 47 56 53 51 46 44 46 51 54 57 60
Change (%) 11.39 6.11 24.46 6.75 -2.77 6.49 4.15 11.34 -0.50 19.98 -5.89 -3.29 -10.33 -3.79 4.94 9.27 5.92 6.61 5.64
% of Revenue 60.02 57.92 56.01 49.67 40.66 32.04 29.35 28.64 30.46 61.53 36.38 36.93 40.57 60.55 67.87 83.43 80.97 65.25 65.19 64.67
SG&A 18 22 23 29 38 48 57 64 67 45 70 70 69 56 52 46 45 50 51 54
Change (%) 18.50 6.80 24.37 31.44 25.92 20.07 11.84 4.78 -33.03 55.94 0.43 -2.16 -18.69 -7.98 -10.81 -1.73 11.10 2.64 4.52
% of Revenue 43.93 45.10 43.89 38.89 39.20 40.01 41.32 43.30 43.34 58.93 45.28 49.06 54.53 73.79 79.11 82.64 72.13 60.97 58.65 57.56
R&D 6 7 7 9 10 12 14 14 14 9 14 15 15 12 11 9 7 8 8 9
Change (%) 12.92 4.82 22.26 17.34 16.98 15.18 2.81 1.48 -38.96 64.42 2.56 2.15 -19.17 -9.65 -16.17 -18.47 6.13 1.63 8.58
% of Revenue 14.29 13.97 13.35 11.63 10.46 9.92 9.83 9.47 9.18 11.37 9.21 10.19 11.83 15.92 16.75 16.45 11.91 9.62 9.16 9.34
OpEx 44 52 57 79 112 149 179 195 200 87 191 182 164 101 86 66 66 89 93 98
Change (%) 18.46 9.72 39.58 40.95 33.28 20.31 8.82 2.77 -56.55 119.76 -4.59 -9.79 -38.27 -15.14 -22.95 -0.28 35.08 3.84 5.95
% of Revenue 104.71 107.46 107.44 106.87 115.50 124.77 129.12 131.65 129.23 114.00 123.45 127.06 130.22 133.79 132.28 119.39 105.74 108.67 105.76 105.21
Operating Income -2 -4 -4 -5 -15 -30 -40 -47 -45 -11 -36 -39 -38 -26 -21 -11 -4 -7 -5 -5
Change (%) 82.73 9.48 29.49 194.41 97.17 36.64 16.00 -3.31 -76.40 239.82 6.96 -1.71 -32.80 -18.01 -48.72 -66.69 98.58 -29.13 -3.66
% of Revenue -4.71 -7.46 -7.44 -6.87 -15.50 -24.77 -29.12 -31.65 -29.23 -14.00 -23.45 -27.06 -30.22 -33.79 -32.28 -19.39 -5.74 -8.67 -5.76 -5.21
Interest Expense -0 -0 -0 -0 -1 -1 -0 -0 -1 -1 -2 -1 -1 -1 -1 -1 -1 -0
Change (%) 756.25 142.34 46.08 34.64 -13.63 -28.37 -29.70 210.92 40.20 33.52 -12.34 -16.56 -5.13 -15.87 -25.49 -19.47 -56.13
% of Revenue -0.03 -0.18 -0.34 -0.41 -0.47 -0.38 -0.26 -0.37 -0.57 -0.86 -1.31 -1.91 -1.86 -2.06 -1.54 -0.87 -0.66 -0.27
Net Income 8 2 -21 3 5 -9 -15 -96 -106 -140 -146 -83 -102 -68 -65 -75 -48 -20 -10 -6
Change (%) -74.51 -1,146.85 -116.85 34.66 -289.17 70.76 530.89 10.83 31.44 4.50 -42.90 22.55 -33.48 -5.14 16.31 -36.56 -57.60 -48.42 -46.88
% of Revenue 18.67 4.12 -39.34 4.72 4.88 -7.48 -10.98 -64.90 -68.71 -183.38 -94.43 -58.16 -80.98 -89.65 -99.08 -134.98 -76.06 -24.54 -11.86 -5.92

Source: Capital IQ

Other Listings
DE:BJX1 €22.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista